InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $3.680 0.01 (0.27%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,208 GSK contract, UK clearance for CTVQ, and ASX 200 inclusion 20 Apr 2026 9:46AM $5.840 $3.680 fallen by 36.99%
$2,208 Cleansing Notice 17 Apr 2026 3:28PM $5.995 $3.680 fallen by 38.62%
$2,208 Application for quotation of securities - 4DX 17 Apr 2026 3:21PM $5.995 $3.680 fallen by 38.62%
$2,208 ZSP: Insignia Financial to be removed from S&P/ASX 200 Index 13 Apr 2026 5:11PM $6.790 $3.680 fallen by 45.80%
$2,208 Application for quotation of securities - 4DX 2 Apr 2026 2:58PM $5.640 $3.680 fallen by 34.75%
$2,208 Cleansing Notice 2 Apr 2026 9:09AM $5.950 $3.680 fallen by 38.15%
$2,208 Application for quotation of securities - 4DX 1 Apr 2026 11:09AM $6.020 $3.680 fallen by 38.87%
$2,208 Proposed issue of securities - 4DX 27 Mar 2026 9:59AM $6.280 $3.680 fallen by 41.40%
$2,208 CE Mark for CTVQ and $83M placement to fund EU expansion 27 Mar 2026 9:55AM $6.280 $3.680 fallen by 41.40%
$2,208 CTVQ deployed at Mayo Clinic 25 Mar 2026 9:25AM $4.630 $3.680 fallen by 20.52%
$2,208 Cleansing Notice 18 Mar 2026 4:29PM $3.980 $3.680 fallen by 7.54%
$2,208 Application for quotation of securities - 4DX 18 Mar 2026 4:24PM $3.980 $3.680 fallen by 7.54%
$2,208 Application for quotation of securities - 4DX 13 Mar 2026 3:07PM $4.130 $3.680 fallen by 10.90%
$2,208 Update - S&P DJI March 2026 Rebalance of the All Ordinaries 10 Mar 2026 5:28PM $4.430 $3.680 fallen by 16.93%
$2,208 S&P DJI Announces March 2026 Quarterly Rebalance 6 Mar 2026 5:05PM $4.330 $3.680 fallen by 15.01%
$2,208 Change of Director's Interest Notice GM & RF 4 Mar 2026 4:07PM $4.070 $3.680 fallen by 9.58%
$2,208 Cleansing Notice 4 Mar 2026 4:00PM $4.070 $3.680 fallen by 9.58%
$2,208 Application for quotation of securities - 4DX 4 Mar 2026 3:54PM $4.090 $3.680 fallen by 10.02%
$2,208 Application for quotation of securities - 4DX 27 Feb 2026 3:18PM $3.790 $3.680 fallen by 2.90%
$2,208 Appendix 4D and FY26 Half Year Report 27 Feb 2026 8:47AM $3.720 $3.680 fallen by 1.08%
$2,208 Application for quotation of securities - 4DX 20 Feb 2026 3:14PM $3.930 $3.680 fallen by 6.36%
$2,208 Application for quotation of securities - 4DX 13 Feb 2026 3:11PM $3.575 $3.680 risen by 2.94%
$2,208 Application for quotation of securities - 4DX 30 Jan 2026 3:28PM $3.480 $3.680 risen by 5.75%
$2,208 Response to ASX Query Letter 30 Jan 2026 2:55PM $3.555 $3.680 risen by 3.52%
$2,208 University of Chicago Medicine adopts CTVQ 30 Jan 2026 10:25AM $3.430 $3.680 risen by 7.29%

51 - 75 of 591 results

Page 3 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.